Helga Stopper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Helga Stopper has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Nicole Schupp
Institute of Toxicology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf
3 shared publications Ursula Schmid
Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany
2 shared publicationsAugust Heidland
Department of Internal Medicine, University of Würzburg, Würzburg, Germany
1 shared publication- Gholamreza Fazeli
Rudolf Virchow Zentrum (RVZ), Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany
1 shared publication Rajaraman Gnana Oli
Department of Toxicology, University of Wuerzburg, Versbacherstr. 9, Wuerzburg, Germany
1 shared publicationSuresh K. Abraham
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
1 shared publication
Latest Publications
- 28 September 2010
- Published by Wiley in Brain Pathology
- Vol. 21 (3) , 237-248
The Role of the Dopamine Transporter in Dopamine‐Induced DNA Damage
The neurotransmitter dopamine causes DNA damage, oxidative stress and is involved in the pathology of neurological diseases. To elucidate this potential link we investigated the mechanism of dopamine‐induced DNA damage. We studied the role of the dopamine transporter (DAT) in MDCK and MDCK‐DAT cells, containing the human DAT gene. After treatment with dopamine, only MDCK‐DAT cells showed elevated chromosomal damage and dopamine uptake. Although stimulation of dopamine type 2 receptor (D2R) with quinpirole in the absence of dopamine did not induce genotoxicity in rat neuronal PC12 cells, interference with D2R signaling by inhibition of G‐proteins, phosphoinositide 3 kinase and extracellular signal‐regulated kinases reduced dopamine‐induced genotoxicity and affected the ability of DAT to take up dopamine. Furthermore, the D2R antagonist sulpiride inhibited the dopamine‐induced migration of DAT from cytosol to cell membrane. To determine whether oxidation of dopamine by monoamine oxidase (MAO) is relevant in its genotoxicity, we inhibited MAO, which reduced the formation of micronuclei and of the oxidative DNA adduct 8‐oxodG. Overall, dopamine exerted its genotoxicityin vitroupon transport into the cells and oxidation by MAO. D2R signaling was involved in the genotoxicity of dopamine by affecting activation and cell surface expression of DAT and hence modulating dopamine uptake.
- 28 September 2010
- Published by Wiley in Brain Pathology
- Vol. 21 (3) , 237-248
The Role of the Dopamine Transporter in Dopamine‐Induced DNA Damage
The neurotransmitter dopamine causes DNA damage, oxidative stress and is involved in the pathology of neurological diseases. To elucidate this potential link we investigated the mechanism of dopamine‐induced DNA damage. We studied the role of the dopamine transporter (DAT) in MDCK and MDCK‐DAT cells, containing the human DAT gene. After treatment with dopamine, only MDCK‐DAT cells showed elevated chromosomal damage and dopamine uptake. Although stimulation of dopamine type 2 receptor (D2R) with quinpirole in the absence of dopamine did not induce genotoxicity in rat neuronal PC12 cells, interference with D2R signaling by inhibition of G‐proteins, phosphoinositide 3 kinase and extracellular signal‐regulated kinases reduced dopamine‐induced genotoxicity and affected the ability of DAT to take up dopamine. Furthermore, the D2R antagonist sulpiride inhibited the dopamine‐induced migration of DAT from cytosol to cell membrane. To determine whether oxidation of dopamine by monoamine oxidase (MAO) is relevant in its genotoxicity, we inhibited MAO, which reduced the formation of micronuclei and of the oxidative DNA adduct 8‐oxodG. Overall, dopamine exerted its genotoxicityin vitroupon transport into the cells and oxidation by MAO. D2R signaling was involved in the genotoxicity of dopamine by affecting activation and cell surface expression of DAT and hence modulating dopamine uptake.
- 31 January 2008
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 18 (1) , 127-133
New Approaches for the Treatment of Genomic Damage in End-Stage Renal Disease
- 31 January 2008
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 18 (1) , 127-133
New Approaches for the Treatment of Genomic Damage in End-Stage Renal Disease
- 2 July 2007
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 51 (7) , 880-887
Antigenotoxic effects of the phytoestrogen pelargonidin chloride and the polyphenol chlorogenic acid
Pelargonidin (PEL), a common anthocyanidin with estrogenic activity, was tested in HL‐60 cells for its genotoxicity and possible antigenotoxic effects against 4‐nitroquinoline 1‐oxide (NQO), a potent mutagen and carcinogen which induces oxidative stress. To take into account potential interactions between phytochemicals within normal human nutrition, we evaluated a combination of PEL with the nonestrogenic phytochemical chlorogenic acid (CLA), one of the most abundant polyphenols in the human diet. PEL (⪇2 μM) and CLA (⪇800 μM) were nongenotoxic in the micronucleus test. We observed significant antigenotoxic effects against NQO with both compounds, but no additive interaction of PEL and CLA. Comet assay results showed a nonsignificant reduction in NQO‐induced DNA damage with both compounds and their combination. Flow cytometric analysis of oxidative stress revealed significant protection against NQO‐induced oxidative stress by PEL, CLA, and their combination. Furthermore, PEL and CLA prevented the NQO‐induced reduction in GSH level. This could be a mechanism for the observed reduction in genotoxicity. In conclusion, the phytoestrogen PEL revealed antioxidative and antigenotoxic properties in HL‐60 cells, but no significant additive interaction with the abundant nutritional polyphenol CLA under the tested conditions.
- 2 July 2007
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 51 (7) , 880-887
Antigenotoxic effects of the phytoestrogen pelargonidin chloride and the polyphenol chlorogenic acid
Pelargonidin (PEL), a common anthocyanidin with estrogenic activity, was tested in HL‐60 cells for its genotoxicity and possible antigenotoxic effects against 4‐nitroquinoline 1‐oxide (NQO), a potent mutagen and carcinogen which induces oxidative stress. To take into account potential interactions between phytochemicals within normal human nutrition, we evaluated a combination of PEL with the nonestrogenic phytochemical chlorogenic acid (CLA), one of the most abundant polyphenols in the human diet. PEL (⪇2 μM) and CLA (⪇800 μM) were nongenotoxic in the micronucleus test. We observed significant antigenotoxic effects against NQO with both compounds, but no additive interaction of PEL and CLA. Comet assay results showed a nonsignificant reduction in NQO‐induced DNA damage with both compounds and their combination. Flow cytometric analysis of oxidative stress revealed significant protection against NQO‐induced oxidative stress by PEL, CLA, and their combination. Furthermore, PEL and CLA prevented the NQO‐induced reduction in GSH level. This could be a mechanism for the observed reduction in genotoxicity. In conclusion, the phytoestrogen PEL revealed antioxidative and antigenotoxic properties in HL‐60 cells, but no significant additive interaction with the abundant nutritional polyphenol CLA under the tested conditions.